Michael did provide an update, of sorts, on the quarterly investor call recently.
The Prilocaine and Lidocaine market is underserved currently due to supply shortages. He elaborated by saying that all supply is sold out as soon as available. Padagis may have 100% of the market in one time period as no competitors have stock and vice versa. In that way the market share statistics aren’t very reliable. But they are selling everything they can produce.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.548M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 351996 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 358041 | 1 |
View Market Depth
| Last trade - 16.21pm 08/08/2025 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable